Loading financials from SEC filings…
Medical care facilities · Healthcare · Fiscal year ends Dec 31
Brookdale Senior Living reported revenue of $3.2B in the fiscal year ended Dec 2025, up 2.2% from the year before. Operating income was $13M, an operating margin of 0.4%, and net income was −$263M. Operating cash flow of $218M less capital expenditure of $202M left free cash flow of $17M. Net debt was $4B.
Ranks among the 24 medical care facilities companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2,758 | 2,825 | 3,016 | 3,125 | 3,194 |
| Gross profit | 501 | 594 | 747 | 799 | 838 |
| Operating income | −217 | −42.7 | 18.4 | 46.5 | 13.5 |
| Interest expense | 195 | 205 | 238 | 253 | – |
| Pre-tax income | −108 | −240 | −180 | −197 | −265 |
| Income tax | −8.2 | −1.6 | 8.8 | 4.6 | −2.0 |
| Net income | −99.3 | −238 | −189 | −202 | −263 |
| Diluted EPS | −0.54 | −1.25 | −0.84 | −0.89 | −1.12 |
| Diluted shares | 185 | 190 | 225 | 228 | 235 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 347 | 399 | 278 | 309 | 279 |
| Receivables | 51.1 | 55.8 | 48.4 | 51.9 | 67.7 |
| Current assets | 699 | 637 | 478 | 513 | 554 |
| Net PP&E | 4,904 | 4,536 | 4,331 | 4,594 | 4,273 |
| Goodwill | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 |
| Total assets | 6,410 | 5,937 | 5,573 | 6,336 | 5,952 |
| Payables | 76.1 | 71.0 | 66.5 | 65.5 | 75.1 |
| Current liabilities | 632 | 641 | 600 | 580 | 568 |
| Short-term debt | 63.1 | 66.0 | 41.5 | 40.8 | 77.5 |
| Long-term debt | 3,778 | 3,784 | 3,656 | 4,022 | 4,215 |
| Total liabilities | 5,711 | 5,353 | 5,168 | 6,122 | 5,996 |
| Shareholders' equity | 697 | 583 | 404 | 212 | −44.8 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | −94.6 | 3.3 | 163 | 166 | 218 |
| Capital expenditure | 177 | 197 | 233 | 201 | 202 |
| Free cash flow | −271 | −194 | −70.3 | −35.1 | 16.5 |
| Depreciation & amortisation | 345 | 354 | 350 | 368 | 370 |
| Stock-based compensation | 16.3 | 14.5 | 12.0 | 14.2 | 11.9 |
| Share buybacks | 0.0 | 0.0 | – | – | – |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 2.4% | 6.7% | 3.6% | 2.2% |
| Operating income growth (YoY) | – | – | – | 152.7% | −71.0% |
| Gross margin | 18.2% | 21.0% | 24.8% | 25.6% | 26.2% |
| Operating margin | −7.9% | −1.5% | 0.6% | 1.5% | 0.4% |
| Net margin | −3.6% | −8.4% | −6.3% | −6.5% | −8.2% |
| Return on equityBlank when equity is negative | −14.2% | −40.9% | −46.8% | −95.0% | – |
| ROCEEBIT ÷ (assets − current liabilities) | −3.8% | −0.8% | 0.4% | 0.8% | 0.3% |
| Free cash flow margin | −9.8% | −6.9% | −2.3% | −1.1% | 0.5% |
| Cash conversion (CFO ÷ net income) | 0.95x | −0.01x | −0.86x | −0.82x | −0.83x |
| Receivable days | 7 | 7 | 6 | 6 | 8 |
| Payable days | 12 | 12 | 11 | 10 | 12 |
| Interest cover | −1.11x | −0.21x | 0.08x | 0.18x | – |
| Debt ÷ equity | 5.51x | 6.61x | 9.16x | 19.1x | – |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 3,494 | 3,451 | 3,419 | 3,754 | 4,013 |
| Current ratio | 1.11x | 0.99x | 0.80x | 0.88x | 0.98x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.